Recalls / Active ingredient / Fosaprepitant Dimeglumine
Fosaprepitant Dimeglumine
2 FDA drug recalls involving the active ingredient “Fosaprepitant Dimeglumine”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-01-10 | Class II | Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconst | BE PHARMACEUTICALS AG |
| 2020-07-13 | Class III | Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx only, Fresenius Kabi, Lake Zurich, | Fresenius Kabi USA, LLC |